Position in BIOA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$778,020
-$2,553,334 QoQ
Shares Held
31,743
-83.3% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 151 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $609,159,561 across 30 Drug Manufacturers - Specialty & Generic names. BIOA ranks #24 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
4,217,767 | $146,229,981 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
4,432,350 | $109,080,132 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
773,978 | $85,865,119 | |
| 4 | ALKS |
Alkermes plc.
|
969,954 | $50,825,589 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
270,754 | $45,632,878 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
2,025,356 | $29,347,408 | |
| 7 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
1,066,322 | $21,518,377 | |
| 8 | ZTS |
Zoetis Inc.
|
257,470 | $18,501,794 |
All Filings in BIOA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $778,020 | 31,743 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $3,331,354 | 190,472 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $2,949,602 | 222,948 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $1,024,272 | 174,196 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $936,638 | 226,789 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $200,787 | 53,401 | Shares | Other | 2025-05-15 | |
| 2024-09-30 | $4,159,999 | 200,000 | Shares | Other | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||